Health/Science/Wellness, Technology Solutions and Trends

#207: Dennis O’Neill, Biomedican

Cannabinoid Connect 207: Dennis O'Neill, Biomedican

Dennis O’Neill is the President at Biomedican, a biotech start-up company which developed a unique patented method of producing non-GMO rare cannabinoids like CBG, CBGA and THCV, THCVA.

Topics Discussed:

  • Biomedican’s unique patented method of producing non-GMO rare cannabinoids
  • Types of cannabinoid synthesis
  • Non-GMO organic cannabis vs. chemically synthesized compounds

Listen to the full episode

Watch on YouTube

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *